OverviewChartNewsTraderScreen

DZ Bank Call 1.8992 MDGD 20.09.20.../  DE000DJ26WV5  /

Frankfurt Zert./DZB
2024-06-20  5:04:54 PM Chg.0.000 Bid5:36:04 PM Ask- Underlying Strike price Expiration date Option type
0.001EUR 0.00% 0.001
Bid Size: 3,500		 -
Ask Size: -		 MEDIGENE AG NA O.N. 1.8992 EUR 2024-09-20 Call
GlobeNewswire 2:00 PM Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumor...
GlobeNewswire 06-11 Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer
GlobeNewswire 05-28 Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...
GlobeNewswire 05-21 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire 05-15 Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS
GlobeNewswire 05-14 Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise
GlobeNewswire 05-07 Medigene to Present at Upcoming Conferences
GlobeNewswire 05-06 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire 05-02 Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell R...
GlobeNewswire 05-02 Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
GlobeNewswire 04-26 Medigene AG reports Financial Results and Business Update for Q1 2024
GlobeNewswire 04-25 Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
GlobeNewswire 04-17 Medigene to Present at Upcoming Scientific Conferences
GlobeNewswire 04-08 Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR ...
GlobeNewswire 04-04 Medigene AG Secures European Patent for its iM-TCR Technology
GlobeNewswire 03-28 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 03-19 Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
GlobeNewswire 03-18 Medigene AG to report full year 2023 financial results on March 28, 2024
GlobeNewswire 03-06 Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Pr...
GlobeNewswire 03-04 Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety...
GlobeNewswire 02-29 Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentia...
GlobeNewswire 02-19 Medigene to Present at Upcoming Conferences
GlobeNewswire 02-12 Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR...
GlobeNewswire 2023-12-19 Medigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 2023-11-21 Medigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cas...